ArticleFrontiers in immunology2022

Genomic alteration of MTAP/CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates response to immune checkpoint blockade in renal cell carcinoma.

Wenhao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.